Screening Quality Assurance visit report – York and Scarborough Teaching Hospitals NHS Foundation Trust

NHS Cervical Screening Programme
13 – 14 September 2022

Scope of this report

 TopicCovered by this report?If ‘no’, where you can find information about this part of the pathway
Underpinning functions
Uptake and coverageYesNot applicable
WorkforceYesNot applicable
IT and equipmentYesNot applicable
CommissioningDescriptive onlyCovers Yorkshire and Humber Public Health Programmes Team
Leadership and governanceYesNot applicable
Pathway
Cohort identificationNoCervical Screening Administration Service
Invitation and informationNoCervical Screening Administration Service
Testing and resultsNoGateshead Health NHS Foundation Trust
ReferralNoNot applicable
DiagnosisYesNot applicable
Intervention / treatmentNoQA visit to colposcopy York and Scarborough hospitals were undertaken in September 2019

Summary

The NHS Cervical Screening Programme invites women between the ages of 25 and 64 for regular cervical screening. This aims to detect abnormalities within the cervix that could, if undetected and untreated, develop into cervical cancer.

The findings in this report relate to the quality assurance visit on 13 and 14 September 2022 to York and Scarborough Teaching Hospitals NHS Foundation Trust cervical screening service which is commissioned by Yorkshire and Humber Public Health Programmes Team. Any commissioning findings are outside the scope of this report and will be followed up directly with the commissioner.

Quality assurance purpose and approach

Quality assurance (QA) aims to achieve and maintain national standards, promote continuous improvement in cervical screening and support reducing health inequalities. This is to ensure that all eligible people have access to a consistent, high quality, effective, equitable and safe service wherever they live.

QA visits are carried out by the NHS England Screening Quality Assurance Service (SQAS).

The evidence for this report comes from the following sources:

  • monitoring of routine data collected by NHS England SQAS
  • data and reports from external organisations
  • information collected during pre-review visits to York and Scarborough Teaching Hospitals NHS Foundation Trust on 5 September 2022
  • information shared with the North regional SQAS as part of the visit process.

The screening service

The York and Scarborough Teaching Hospitals NHS Foundation Trust cervical screening service serves the populations of York, Scarborough, Ryedale, and parts of East Riding. The service has colposcopy units at:

  • Bridlington Hospital
  • Scarborough Hospital
  • The York Hospital

Histopathology services are currently provided by Scarborough, Hull, York Pathology Service Network at:

  • The York Hospital
  • Hull Royal Infirmary Hospital

The Hull laboratory provide histopathology services for Hull Royal Infirmary (Hull University Teaching Hospitals NHS Trust) colposcopy service.

Findings

The Cervical Screening Provider Lead (CSPL) was newly appointed to the role in April 2022. They have undertaken a review and gap analysis of the CSPL role responsibilities and requirements and attended the national training. The CSPL has engaged with the cervical screening service pathway to improve understanding and develop relationships.   

The Scarborough, Hull, York, pathology service was formally established on 1 November 2021. It brings together histopathology staff and services from York and Scarborough Hospitals NHS Foundation Trust (YSTH) and Hull University Teaching Hospitals NHS Trust (HUTH). The collaboration of the two cervical screening histopathology services is in its early stages. The Head Biomedical Scientist was appointed in a collaborative role to work across both sites to support cervical specimen processing consistency and align cervical screening histopathology protocols.

The YSTH cervical screening service supports people who are considered vulnerable or underserved but does not have an overarching strategy to systematically identify and reduce inequalities.

Immediate concerns

The QA visit team identified no immediate concerns.

Urgent recommendations

The QA visit team identified one urgent recommendation. A letter was sent to the cervical screening provider lead on 16 September 2022 asking that the following item is addressed:

  • Process map the histopathology specimen pathway to identify delays for outsourced cervical specimens from the Hull laboratory and take action to improve the turnaround times

A response including an action plan has been received informing the QA visit team the steps taken to resolve the urgent recommendation.

High priority findings

The QA visit team identified 3 high priority findings as summarised below:

  • Leadership and accountability of the NHS Cervical Screening Programme (NHSCSP) histopathology service across both sites 
  • Inadequate pathologist workforce on both sites in particular the Hull site where all cervical biopsies are sent to an outsourcing provider for reporting
  • York laboratory facilities is limited on space with some pathologists sharing office space for reporting and the laboratory booking in environment and processing of NHSCSP samples

Examples of practice that can be shared

The QA visit team identified several areas of practice for sharing, including:

  • Experienced Head Biomedical Scientist for cellular pathology working across both sites to support cross-site laboratory technical working and to develop consistent processes
  • Cervical screening programme specimen workflow lean and efficient at both sites

Recommendations

The following recommendations are for the provider to action unless otherwise stated.

No.RecommendationPathway themeReferenceTimescalePriorityEvidence required
Urgent recommendation
01Process map the histopathology sample pathway to identify delays for outsourced samples from Hull and take action to improve turnaround timesDiagnosis – histology514 daysUrgentAction plan, improved turnaround times
No.RecommendationReferenceTimescalePriorityEvidence required
Governance and leadership
02Develop an action plan to reduce screening inequalities in underserved and protected population groups in NHS Cervical Screening Programme pathway16 monthsStandardAction plan
03Implement a whole trust organisational accountability structure for the cervical screening service, including detail of escalation routes for governance and performance issues26 monthsHighRatified documents outlining accountability arrangements
04Make sure the Cervical Screening Provider Lead administrative support role is documented in their job description23 monthsHighJob description
05Make sure the Cervical Screening Provider Lead has an annual appraisal for the role212 monthsStandardConfirmation of appraisal
06Develop cervical screening management meetings terms of reference23 monthsStandardTerms of reference
07Ratify trust-wide protocol for the completion of the invasive cervical cancer audit26 monthsStandardRatified protocol
08Ratify trust-wide policy for the offer of disclosure of invasive cervical cancer audit2  6 monthsStandardRatified policy
09Make sure all people diagnosed with cervical cancer have been offered the results of theinvasive cervical cancer audit2  3 monthsHighCompletion of offer of disclosure for cases diagnosed
10Implement an annual audit of disclosurefor the invasive cervical cancer audit212 monthsStandardAudit schedule, audit
11Make sure the annual performance report and 6 monthly update to cover all NHSCSP services is provided to the trust clinical governance committee26 monthsStandardAnnual performance and 6 monthly report with circulation list
12Develop and implement a whole trust annual audit schedule for cervical screening services212 monthsStandardAnnual audit schedule covering colposcopy and histopathology with confirmatory evidence of actions taken
13Document the process for results and referral for cervical samples taken in the trust outside of colposcopy26 monthsStandardRatified protocol
14Amend trust-wide incident policy to accurately document reporting incidents to Screening Quality Assurance Service26 monthsStandardRatified protocol
15Appoint a Lead NHSCSP Histopathologist across the pathology network with responsibility for ensuring good practice, compliance with protocols and standards are met  5  3 monthsHighJob description, job plan with dedicated professional activity allocation
Diagnosis – histology 
16Ensure that the Lead NHSCSP Histopathologist has overall responsibility for all outsourced specimens53 monthsHighConfirmation of oversight and responsibility
17Make sure that all NHSCSP reporting pathologists have completed e-learning56 monthsStandardConfirmation of completion
18Develop a workforce plan to sustainably meet turnaround times for reporting NHS Cervical Screening Programme histopathology112 monthsHighWorkforce plan
19Risk assessment of York site accommodation, including the impact of shared pathologists’ office space for safe reporting, and the booking in environment for NHSCSP samples56 monthsHighRisk assessment
20Ensure York histopathology staff have access to Open Exeter56 monthsStandardConfirmation
21Implement trust-wide standard operating procedures for processing and reporting of NHS Cervical Screening Programme specimens56 monthsHighRatified standard operating procedures
22Put in place a process to ensure that the Lead Histopathologist for NHSCSP can monitor histopathology performance data56 monthsStandardProtocol
23Document sample selection criteria for p16 staining 53 monthsStandardStandard operating procedure
24Develop a standard operating procedure for the reporting of NHSCSP incidents to include the escalation process to cervical screening provider lead56 monthsStandardStandard operating procedure
25Make sure that all NHSCSP reporting pathologists meet the minimum number of cervical screening specimen reporting512 monthsStandardIndividual histopathologist workload data
26Make sure that proforma forms for reporting cervical histopathology are used for all NHS Cervical Screening Programme specimens56 monthsStandardProforma form, re- audit of individual pathologist compliance
Multidisciplinary team
27Make sure that all NHSCSP reporting pathologists meet the minimum requirement NHSCSP MDT attendance criteria512 monthsStandardEvidence of multidisciplinary team meeting attendance
28Document the second review by a pathologist different from the original reporter for histology cases for colposcopy multidisciplinary team meetings53 monthsStandardRatified standard operating procedure
29Make sure there are appropriate arrangements for histopathology representation at Hull MDT for holiday/sickness absence53 monthsStandardConfirmation

Next steps

The screening service provider is responsible for developing an action plan in collaboration with the commissioners to complete the recommendations contained within this report.

SQAS will work with commissioners to monitor activity and progress of the recommendations for 12 months after the report is published. After this point SQAS will send a letter to the provider and commissioners summarising the progress made and will outline any further action(s) needed.

Appendix B: References

  1. NHS England. NHS Public Health Functions Agreement: 2022/23 Service Specification No.25 Cervical Screening Service Schedule 2
  2. NHS Cervical Screening Programme. Cervical screening: role of the cervical screening provider Lead;
  3. NHS Cervical Screening Programme. Cervical screening: auditing procedures; 2021.
  4. NHS Cervical Screening Programme. Cervical screening: disclosure of audit results toolkit; 2021.
  5. NHS Cervical Screening Programme. Cervical screening: histopathology reporting handbook; 2021.
  6. Ministry of Housing, Communities & Local Government. English indices of deprivation; 2019.
  7. Official Census and Labour Market Statistics. LC2101EW – Ethnic group by sex by age; 2011
  8. Official Census and Labour Market Statistics. LC2107EW – Religion by sex by age; 2011
  9. NHS England. Quarterly Cervical Coverage Report; March 2022.